JHVEPhoto/iStock Editorial via Getty Images
Teva Pharmaceutical (NYSE:TEVA) announced on Wednesday that the U.S. Food and Drug Administration (FDA) approved its migraine therapy Ajovy for children and adolescents, expanding its previous label indicated for adults.
The single-dose injectable was first approved by the FDA in